Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 49

1.

The effect of task modality and stimulus frequency in paced serial addition tests on functional brain activity.

Gielen J, Wiels W, Van Schependom J, Laton J, Van Hecke W, Parizel PM, D'hooghe MB, Nagels G.

PLoS One. 2018 Mar 15;13(3):e0194388. doi: 10.1371/journal.pone.0194388. eCollection 2018.

2.

Definition, prevalence and predictive factors of benign multiple sclerosis.

Reynders T, D'haeseleer M, De Keyser J, Nagels G, D'hooghe MB.

eNeurologicalSci. 2017 May 13;7:37-43. doi: 10.1016/j.ensci.2017.05.002. eCollection 2017 Jun. Review.

3.

Does including the full CVLT-II and BVMT-R improve BICAMS? Evidence from a Belgian (Dutch) validation study.

Costers L, Gielen J, Eelen PL, Schependom JV, Laton J, Remoortel AV, Vanzeir E, Wijmeersch BV, Seeldrayers P, Haelewyck MC, D'Haeseleer M, D'hooghe MB, Langdon D, Nagels G.

Mult Scler Relat Disord. 2017 Nov;18:33-40. doi: 10.1016/j.msard.2017.08.018. Epub 2017 Sep 7.

PMID:
29141818
4.

Electronic visual analogue scales for pain, fatigue, anxiety and quality of life in people with multiple sclerosis using smartphone and tablet: a reliability and feasibility study.

Kos D, Raeymaekers J, Van Remoortel A, D'hooghe MB, Nagels G, D'Haeseleer M, Peeters E, Dams T, Peeters T.

Clin Rehabil. 2017 Sep;31(9):1215-1225. doi: 10.1177/0269215517692641. Epub 2017 Feb 17.

PMID:
28786335
5.

Self-reported levels of education and disability progression in multiple sclerosis.

D'hooghe MB, Haentjens P, Van Remoortel A, De Keyser J, Nagels G.

Acta Neurol Scand. 2016 Dec;134(6):414-419. doi: 10.1111/ane.12555. Epub 2016 Jan 6.

PMID:
27761897
6.

The effectiveness of a self-management occupational therapy intervention on activity performance in individuals with multiple sclerosis-related fatigue: a randomized-controlled trial.

Kos D, Duportail M, Meirte J, Meeus M, D'hooghe MB, Nagels G, Willekens B, Meurrens T, Ilsbroukx S, Nijs J.

Int J Rehabil Res. 2016 Sep;39(3):255-62. doi: 10.1097/MRR.0000000000000178.

PMID:
27182847
7.

Cerebral hypoperfusion: a new pathophysiologic concept in multiple sclerosis?

D'haeseleer M, Hostenbach S, Peeters I, Sankari SE, Nagels G, De Keyser J, D'hooghe MB.

J Cereb Blood Flow Metab. 2015 Sep;35(9):1406-10. doi: 10.1038/jcbfm.2015.131. Epub 2015 Jun 24. Review.

8.

Multiparity in women with multiple sclerosis causes less long-term disability: yes.

D'hooghe MB, De Keyser J.

Mult Scler. 2014 Oct;20(11):1432-4. doi: 10.1177/1352458514534105. Review. No abstract available.

PMID:
25344546
9.

Reduced information processing speed as primum movens for cognitive decline in MS.

Van Schependom J, D'hooghe MB, Cleynhens K, D'hooge M, Haelewyck MC, De Keyser J, Nagels G.

Mult Scler. 2015 Jan;21(1):83-91. doi: 10.1177/1352458514537012. Epub 2014 Jul 10.

PMID:
25013149
10.

Impact of a 5-day expedition to machu picchu on persons with multiple sclerosis.

D'hooghe MB, Feys P, Deltour S, Van de Putte I, De Meue J, Kos D, O Eijnde B, Van Asch P.

Mult Scler Int. 2014;2014:761210. doi: 10.1155/2014/761210. Epub 2014 May 21.

11.

Except for C-C chemokine receptor 7 expression, monocyte-derived dendritic cells from patients with multiple sclerosis are functionally comparable to those of healthy controls.

Nuyts AH, Ponsaerts P, Van Tendeloo VF, Lee WP, Stein B, Nagels G, D'hooghe MB, Willekens B, Cras P, Wouters K, Goossens H, Berneman ZN, Cools N.

Cytotherapy. 2014 Jul;16(7):1024-30. doi: 10.1016/j.jcyt.2014.02.016. Epub 2014 May 20.

12.

The Symbol Digit Modalities Test as sentinel test for cognitive impairment in multiple sclerosis.

Van Schependom J, D'hooghe MB, Cleynhens K, D'hooge M, Haelewyck MC, De Keyser J, Nagels G.

Eur J Neurol. 2014 Sep;21(9):1219-25, e71-2. doi: 10.1111/ene.12463. Epub 2014 May 22.

PMID:
24850580
13.

Graph theoretical analysis indicates cognitive impairment in MS stems from neural disconnection.

Van Schependom J, Gielen J, Laton J, D'hooghe MB, De Keyser J, Nagels G.

Neuroimage Clin. 2014 Jan 31;4:403-10. doi: 10.1016/j.nicl.2014.01.012. eCollection 2014.

14.

Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial.

Confavreux C, O'Connor P, Comi G, Freedman MS, Miller AE, Olsson TP, Wolinsky JS, Bagulho T, Delhay JL, Dukovic D, Truffinet P, Kappos L; TOWER Trial Group.

Lancet Neurol. 2014 Mar;13(3):247-56. doi: 10.1016/S1474-4422(13)70308-9. Epub 2014 Jan 23.

PMID:
24461574
15.

Relative contribution of cognitive and physical disability components to quality of life in MS.

Van Schependom J, D'hooghe MB, De Schepper M, Cleynhens K, D'hooge M, Haelewyck MC, De Keyser J, Nagels G.

J Neurol Sci. 2014 Jan 15;336(1-2):116-21. doi: 10.1016/j.jns.2013.10.020. Epub 2013 Oct 19.

PMID:
24176242
16.

Consensus guidelines on the neurologist's role in the management of neurogenic lower urinary tract dysfunction in multiple sclerosis.

De Ridder D, Van Der Aa F, Debruyne J, D'hooghe MB, Dubois B, Guillaume D, Heerings M, Ilsbroukx S, Medaer R, Nagels G, Seeldrayers P, Van Landegem W, Willekens B, Zicot AF.

Clin Neurol Neurosurg. 2013 Oct;115(10):2033-40. doi: 10.1016/j.clineuro.2013.06.018. Epub 2013 Jul 20.

PMID:
23880016
17.

A "candidate-interactome" aggregate analysis of genome-wide association data in multiple sclerosis.

Mechelli R, Umeton R, Policano C, Annibali V, Coarelli G, Ricigliano VA, Vittori D, Fornasiero A, Buscarinu MC; International Multiple Sclerosis Genetics Consortium; Wellcome Trust Case Control Consortium,2, Romano S, Salvetti M, Ristori G.

PLoS One. 2013 May 16;8(5):e63300. doi: 10.1371/journal.pone.0063300. Print 2013.

18.

Female gender and reproductive factors affecting risk, relapses and progression in multiple sclerosis.

D'hooghe MB, D'Hooghe T, De Keyser J.

Gynecol Obstet Invest. 2013;75(2):73-84. doi: 10.1159/000346319. Epub 2013 Jan 18. Review. Erratum in: Gynecol Obstet Invest. 2013;76(1):73.

PMID:
23343711
19.

Self-reported health promotion and disability progression in multiple sclerosis.

D'hooghe MB, Nagels G, De Keyser J, Haentjens P.

J Neurol Sci. 2013 Feb 15;325(1-2):120-6. doi: 10.1016/j.jns.2012.12.018. Epub 2013 Jan 4.

PMID:
23294496
20.

Associations of alcohol consumption with clinical and MRI measures in multiple sclerosis.

D'hooghe MB, De Keyser J.

Expert Rev Neurother. 2012 Jun;12(6):657-60. doi: 10.1586/ern.12.44.

PMID:
22650167

Supplemental Content

Loading ...
Support Center